July 2021 edition : Leading Better Value Care
The Breast Cancer Hypofractionation Initiative aims to assess and address the variation observed in hypofractionated radiation therapy for the treatment of early-stage breast cancer and improve access to hypofractionated radiation therapy for women across the state.
Hypofractionated radiation therapy for women with early‑stage breast cancer has been increasingly used in NSW. However, variation in its use in NSW has been observed.
The Cancer Institute NSW began the project planning and initiation of the Leading Better Value Care initiative in 2018.
The initiative is now in its sustainability phase. Key lessons learned include the importance of regular reporting to key stakeholders, as well as understanding the barriers and enablers to the use of hypofractionated radiation therapy in designing and implementing the initiative.
Cancer Institute NSW website